DK0537007T3 - Anvendelse af farnesyl-protein-transferase-inhibitorer til fremstilling af et lægemiddel til blokering af neoplastisk transformation af celler fremkaldt af ras-oncogener - Google Patents
Anvendelse af farnesyl-protein-transferase-inhibitorer til fremstilling af et lægemiddel til blokering af neoplastisk transformation af celler fremkaldt af ras-oncogenerInfo
- Publication number
- DK0537007T3 DK0537007T3 DK92309184.7T DK92309184T DK0537007T3 DK 0537007 T3 DK0537007 T3 DK 0537007T3 DK 92309184 T DK92309184 T DK 92309184T DK 0537007 T3 DK0537007 T3 DK 0537007T3
- Authority
- DK
- Denmark
- Prior art keywords
- drug
- prepare
- cells induced
- protein transferase
- transferase inhibitors
- Prior art date
Links
- 108700042226 ras Genes Proteins 0.000 title abstract 2
- 231100000504 carcinogenesis Toxicity 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 230000010309 neoplastic transformation Effects 0.000 title 1
- 239000003528 protein farnesyltransferase inhibitor Substances 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 102000043276 Oncogene Human genes 0.000 abstract 1
- 229940121659 Prenyltransferase inhibitor Drugs 0.000 abstract 1
- 230000000903 blocking effect Effects 0.000 abstract 1
- 230000013823 prenylation Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77495791A | 1991-10-11 | 1991-10-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0537007T3 true DK0537007T3 (da) | 1995-09-25 |
Family
ID=25102836
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK92309184.7T DK0537007T3 (da) | 1991-10-11 | 1992-10-08 | Anvendelse af farnesyl-protein-transferase-inhibitorer til fremstilling af et lægemiddel til blokering af neoplastisk transformation af celler fremkaldt af ras-oncogener |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6087349A (da) |
| EP (1) | EP0537007B1 (da) |
| JP (1) | JPH05221866A (da) |
| AT (1) | ATE126059T1 (da) |
| CA (1) | CA2080172A1 (da) |
| DE (1) | DE69204007T2 (da) |
| DK (1) | DK0537007T3 (da) |
| ES (1) | ES2075630T3 (da) |
| GR (1) | GR3017904T3 (da) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5312814A (en) * | 1992-12-09 | 1994-05-17 | Bristol-Myers Squibb Co. | α-phosphonocarboxylate squalene synthetase inhibitors |
| HUT77406A (hu) * | 1994-03-15 | 1998-04-28 | Eisai Co., Ltd., | 1-(4-Amino-5-tio-pent-2-en)-il oldalláncot tartalmazó peptidomimetikumok és az ezeket tartalmazó gyógyszerkészítmények |
| US5436263A (en) * | 1994-03-22 | 1995-07-25 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| US5420334A (en) * | 1994-04-04 | 1995-05-30 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| US5510371A (en) * | 1994-06-06 | 1996-04-23 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| GB9515975D0 (en) | 1995-08-04 | 1995-10-04 | Zeneca Ltd | Chemical compounds |
| US20020034725A1 (en) * | 1996-04-15 | 2002-03-21 | W. Gillies Mckenna | Sensitization of cells to radiation and and chemotherapy |
| US6946468B1 (en) | 1996-08-17 | 2005-09-20 | Zeneca Limited | 3-mercaptopyrrolidines as farnesyl protein transferase inhibitors |
| FR2780974B1 (fr) * | 1998-07-08 | 2001-09-28 | Sod Conseils Rech Applic | Utilisation de derives d'imidazopyrazines pour preparer un medicament destine a traiter les pathologies qui resultent de la formation de la proteine g heterotrimetrique |
| GB9930318D0 (en) | 1999-12-22 | 2000-02-09 | Zeneca Ltd | Novel compounds |
| GB9930317D0 (en) | 1999-12-22 | 2000-02-09 | Zeneca Ltd | Novel compounds |
| CA2372450A1 (en) * | 2001-05-10 | 2001-09-19 | Pharmaceutical Partners Of Canada Inc. | Liquid injectable formulation of disodium pamidronate |
| WO2005000858A2 (en) | 2003-06-27 | 2005-01-06 | Akira Odani | Bisphosphonate complexes |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4871721A (en) * | 1988-01-11 | 1989-10-03 | E. R. Squibb & Sons, Inc. | Phosphorus-containing squalene synthetase inhibitors |
| EP0356866A3 (en) * | 1988-08-29 | 1991-03-27 | E.R. SQUIBB & SONS, INC. | Phosphorus-containing squalene synthetase inhibitors and method |
| US5196409A (en) * | 1989-08-20 | 1993-03-23 | Yissum, Research Development Company Of The Hebrew University Of Jerusalem | Bisphosphonates, pharmaceutical compositions, and process for the treatment of irregularities in calcium metabolism |
| US5025003A (en) * | 1989-09-18 | 1991-06-18 | E. R. Squibb & Sons, Inc. | Isoprenoid phosphinylformic acid squalene synthetase inhibitors |
| US5185248A (en) * | 1990-05-08 | 1993-02-09 | E. R. Squibb & Sons, Inc. | Farnesyl-protein transferase assay for identifying compounds that block neoplastic transformation |
-
1992
- 1992-10-08 EP EP92309184A patent/EP0537007B1/en not_active Revoked
- 1992-10-08 DK DK92309184.7T patent/DK0537007T3/da active
- 1992-10-08 CA CA002080172A patent/CA2080172A1/en not_active Abandoned
- 1992-10-08 ES ES92309184T patent/ES2075630T3/es not_active Expired - Lifetime
- 1992-10-08 AT AT92309184T patent/ATE126059T1/de not_active IP Right Cessation
- 1992-10-08 DE DE69204007T patent/DE69204007T2/de not_active Revoked
- 1992-10-12 JP JP92272813A patent/JPH05221866A/ja active Pending
-
1995
- 1995-10-27 GR GR950403003T patent/GR3017904T3/el unknown
-
1998
- 1998-05-06 US US09/081,972 patent/US6087349A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE69204007T2 (de) | 1996-03-21 |
| CA2080172A1 (en) | 1993-04-12 |
| DE69204007D1 (de) | 1995-09-14 |
| EP0537007B1 (en) | 1995-08-09 |
| GR3017904T3 (en) | 1996-01-31 |
| ATE126059T1 (de) | 1995-08-15 |
| ES2075630T3 (es) | 1995-10-01 |
| JPH05221866A (ja) | 1993-08-31 |
| EP0537007A1 (en) | 1993-04-14 |
| US6087349A (en) | 2000-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0537007T3 (da) | Anvendelse af farnesyl-protein-transferase-inhibitorer til fremstilling af et lægemiddel til blokering af neoplastisk transformation af celler fremkaldt af ras-oncogener | |
| FI952010A0 (fi) | Farnesyyliproteiinitransferaasin estäjät | |
| FI952011L (fi) | Farnesyyliproteiinitransferaasin estäjät | |
| EP0735870A4 (en) | Use of pla 2? inhibitors as treatment for alzheimer's disease | |
| NO923908L (no) | Fremgangsmaate for inhibering av hydratdannelse | |
| NO941181D0 (no) | Heterocykliske inhibitorer for farnesyl-protein-transferase | |
| FI961819A0 (fi) | Proteiini:farnesyylitransferaasin substituoidut di- ja tripeptidi-inhibiittorit | |
| DE69303718D1 (de) | Verband zur dosierung eines oder mehrerer medikamenten | |
| DE69422907D1 (de) | Vorrichtung zum in-line verabreichen einer arznei | |
| DE69221501D1 (de) | Verfahren zum vermindern von durch medizinische vorrichtungen bedingten infektionen | |
| AU7107496A (en) | Protein tyrosine kinase inhibitors for treating osteoarthritis | |
| DE69215818D1 (de) | Verfahren zur sicheren Zugangskontrolle | |
| FI945311A7 (fi) | Oksibutyniinin transdermaalinen annostelu | |
| NO931947L (no) | Fremgangsmaate for korrosjons-hemming | |
| DE69214610D1 (de) | Verfahren zur Behandlung von Erdgas | |
| DK130387D0 (da) | Transglutaminase inhibitorer | |
| ATE176399T1 (de) | Verfahren zur inaktivierung von spermien | |
| DK0537008T3 (da) | Anvendelse af bisphosphater til fremstilling af et lægemiddel til blokering af neoplastisk transformation af celle fremkaldt af ras-oncogener | |
| FI944102A0 (fi) | Kasvaimen kasvua estämään kykenevä proteiiniyhdiste | |
| KR950701303A (ko) | 방향족 비닐 화합물에 대한 중합반응 억제제 | |
| DE59202663D1 (de) | Verwendung eines UV-Strahlers zur Behandlung von Oberflächen. | |
| BR9104888A (pt) | Inibidor e processo para inibicao de polimerizacao de um composto vinila | |
| NO940862D0 (no) | Neurotensinfremgangsmåte for inhibering av vaskulær lekkasje | |
| NO993627L (no) | Anvendelse av en forbindelse for fremstilling av et legemiddel | |
| DE69208759D1 (de) | Salze von N-Nitrosophenylhydroxylamin |